Atlas Trials

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months

Clinical trial NCT00628108 · COMPLETED

Trial details

NCT number
NCT00628108
Sponsor
UCB Pharma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Allergic RhinitisChronic Urticaria
Start date
2008-03-01
Primary completion
2008-09-01
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.